SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-19-002031
Filing Date
2019-03-28
Accepted
2019-03-28 08:00:33
Documents
11
Period of Report
2019-03-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_032719.htm 8-K 14663
2 PRESS RELEASE exh_991.htm EX-99.1 17012
3 PRESS RELEASE exh_992.htm EX-99.2 12987
4 exh991_1.jpg GRAPHIC 29915
5 exh991_2.jpg GRAPHIC 150328
6 exh991_3.jpg GRAPHIC 59942
7 exh991_4.jpg GRAPHIC 52280
8 exh991_5.jpg GRAPHIC 37213
9 exh991_6.jpg GRAPHIC 45696
10 exh991_7.jpg GRAPHIC 57690
11 exh991_8.jpg GRAPHIC 29915
  Complete submission text file 0001171843-19-002031.txt   681720
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 19710000
SIC: 2836 Biological Products, (No Diagnostic Substances)